GPCR/G-Protein
GPCR/G-Protein inhibitors are compounds that target G-protein coupled receptors (GPCRs) and associated G-proteins, which play critical roles in transmitting signals from the outside to the inside of cells. These inhibitors are essential for studying the signaling pathways mediated by GPCRs, which are involved in numerous physiological processes, including sensory perception, immune response, and neurotransmission. GPCR inhibitors are also important in drug development, as many therapeutic agents target these receptors. At CymitQuimica, we offer a wide range of high-quality GPCR/G-Protein inhibitors to support your research in pharmacology, cell biology, and related fields.
Subcategories of "GPCR/G-Protein"
- 5-HT Receptor(1,025 products)
- Adenosine Receptor(249 products)
- Adrenergic Receptor(3,022 products)
- Bombesin Receptor(35 products)
- Bradykinin Receptor(61 products)
- CXCR(158 products)
- CaSR(34 products)
- Cannabinoid Receptor(217 products)
- Cholecystokinin(1 products)
- Dopamine Receptor(445 products)
- Endothelin Receptor(86 products)
- GNRH Receptor(84 products)
- GPCR19(33 products)
- GRK(33 products)
- GTPase(23 products)
- Glucagon Receptor(194 products)
- Hedgehog/Smoothened(49 products)
- Histamine Receptor(385 products)
- LPA Receptor(21 products)
- Melatonin Receptor(26 products)
- OX Receptor(41 products)
- Opioid Receptor(327 products)
- PAFR(14 products)
- PKA(60 products)
- S1P Receptor(18 products)
- SGLT(31 products)
- Sigma receptor(46 products)
Show 19 more subcategories
Found 5983 products of "GPCR/G-Protein"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
LK 204-545
CAS:LK 204-545 is a highly selective antagonist of beta1-adrenoceptor.Formula:C25H32N4O6Color and Shape:SolidMolecular weight:484.54JNJ-28583867
CAS:JNJ-28583867 is an inhibitor of histamine H(3) receptor antagonist and serotonin reuptake.Formula:C24H32N2O2SColor and Shape:SolidMolecular weight:412.59Sonepiprazole
CAS:Sonepiprazole (PNU-101387G) is a chemical compound known for its selective antagonistic properties toward D4 dopamine receptors, exhibiting dissociationFormula:C21H27N3O3SPurity:99.81%Color and Shape:SolidMolecular weight:401.52ATL802
CAS:ATL802 is an adenosine A2B Receptor antagonist.Formula:C24H22F3N7O3Purity:98%Color and Shape:SolidMolecular weight:513.47L 662025
CAS:L 662025 is a PAF receptor antagonist.Formula:C23H27N3O6Purity:98%Color and Shape:SolidMolecular weight:441.48TASP 0277308
CAS:NH2-UAMC1110 TFA is an aminobutoxy derivative of UAMC1110 used in the synthesis of FAPI-QS. UAMC1110 is a fibroblast activating protein (fap) inhibitor.Formula:C23H28Cl2N6O3SColor and Shape:SolidMolecular weight:539.48Firazorexton hydrate
CAS:Firazorexton hydrate (TAK-994) is a brain-penetrant and orally active agonist of the orexin type 2 receptor (OX2R) with a potent EC50 of 19 nM.Formula:C22H25F3N2O4SH2OColor and Shape:SolidMolecular weight:497.53NAD 299 hydrochloride
CAS:Selective, high affinity 5-HT1A receptor antagonistFormula:C18H24ClFN2O2Purity:98%Color and Shape:SolidMolecular weight:354.85RP-23618
CAS:RP-23618 is a non-peptidic antagonist of RANTES.Formula:C30H35N5O3S2Purity:98%Color and Shape:SolidMolecular weight:577.76L-796568 free base
CAS:L-796568 is a potent β3 agonist for obesity with 600x selectivity over β1/β2 receptors (EC50: 3.6 nM).Formula:C31H27F3N4O3S2Color and Shape:SolidMolecular weight:624.7Dersalazine sodium
CAS:Dersalazine, potential ulcerative colitis drug, inhibits PAF & TNFα, reduces inflammation and MPO activity in rats.Formula:C35H32N6NaO4Purity:98%Color and Shape:SolidMolecular weight:623.669LY 53857
CAS:LY 53857 is a potent and selective antagonist of 5-HT2 serotonin receptor.Formula:C27H36N2O7Color and Shape:SolidMolecular weight:500.592CP-96486
CAS:CP-96486 is a potent and orally active antagonist of leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor (Kis: 20 and 24 nM).Formula:C31H23ClN4OPurity:98%Color and Shape:SolidMolecular weight:502.99L-736380
CAS:L-736380, a CCK-B antagonist, reduces gastric acid (ID50: 0.064mg/kg) and blocks [(125)I]CCK-8S in mouse brains (ED50: 1.7mg/kg).Formula:C25H29N9O2Color and Shape:SolidMolecular weight:487.5616-phenoxy tetranor Prostaglandin E2
CAS:16-phenoxy tetranor PGE2, the free acid form of sulprostone, results from the hydrolysis of the methylsulfonamide bond. It is identified as a minor metabolite in human plasma following the parenteral administration of sulprostone.Formula:C22H28O6Color and Shape:SolidMolecular weight:388.46L 659837
CAS:L 659837 is an antagonist of ANC-2, lactam, and tackykinin.Formula:C40H52N8O7SColor and Shape:SolidMolecular weight:788.96PD 160170
CAS:neuropeptide Y1 receptor antagonistFormula:C18H17N3O4SPurity:98%Color and Shape:SolidMolecular weight:371.41Tafluprost ethyl ester
CAS:Tafluprost, an analog of prostaglandin F2α (PGF2α) that primarily targets the FP receptor, is employed in glaucoma treatment. Tafluprost (free acid) serves as a potent FP receptor agonist with a Ki value of 0.4 nM. Its derivative, tafluprost ethyl ester, potentially offers enhanced lipid solubility relative to its free acid form, possibly leading to superior tissue absorption and reduced effective concentration requirements.Formula:C24H32F2O5Color and Shape:SolidMolecular weight:438.512VCH-286
CAS:VCH-286 is a C-C chemokine receptor type 5 (CCR5) receptor antagonist.Formula:C34H50F2N4O3Purity:98%Color and Shape:SolidMolecular weight:600.78UWA-101 hydrochloride
CAS:UWA-101 hydrochloride is a selective, non-cytotoxic inhibitor of DAT/SERT, demonstrating EC50 values of 3.6 µM for DAT and 2.3 µM for SERT inhibition. It mitigates motor disorders and other side effects associated with dopaminergic agent use (e.g., L-DOPA) without exhibiting psychotropic effects. This compound is utilized in research focused on neurodegenerative conditions like Parkinson's disease [1] [2].Formula:C13H18ClNO2Color and Shape:SolidMolecular weight:255.74
